Goldstein et al. used the monoclonal antibody BHQ880 to inhibit Dkk-1 in tumor-bearing mice and showed that the serum levels of this Wnt antagonist are higher in rapidly growing tumors than in large tumors displaying reduced growth rates. Here, DKK1 is linked to neoplasm.